Integrative Pathways to Health and Illness
Integrative Pathways to Health and Illness
批准号:
10707314
负责人:
CAROL D. RYFF
金额:
$678.37万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-07-25 至 2028-08-31
关键词:
AdultAgeAge DistributionAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaArchivesAttentionBaseline SurveysBehavioralBiologicalBiological AssayBiological MarkersBiologyCOVID-19 pandemicChronicClinical Trials Data Monitoring CommitteesCognitiveCommunitiesComplexDataData CollectionData SetDementiaDocumentationDropsEducational workshopElderlyEnsureEventFundingGene ExpressionGene Expression RegulationGenomicsHealthHealth SciencesImpaired cognitionIndividualInequalityInterventionKnowledgeLifeLinkLongitudinal StudiesMeasuresMetadataMethodologyMinorityModelingMonitorMorbidity - disease rateNational ArchiveNeurobiologyNeurosciencesOutcomeParticipantPathway interactionsPersonal SatisfactionPersonsPhysiologyPoliticsPreventionPsychosocial Assessment and CarePsychosocial FactorPublicationsPublishingQuality ControlRecurrenceResearchResourcesRunningSample SizeSamplingStressSurveysTestingTimeTranslatingUniversitiesWorkaffective neuroscienceagedaging brainbiopsychosocialcaregivingcognitive functioncognitive testingcomputerizeddesigndiariesemotion regulationexperiencefollow-upgenomic datahealth inequalitieshealthy agingjournal articlemiddle agemortalityneurobiological mechanismperceived discriminationpreventpromote resilienceprotective factorspsychologicpsychosocialpsychosocial resourcespublic health relevanceracial disparityrecruitresilienceresilience researchsocialsociodemographic factorssociodemographicssocioeconomic disparitysocioeconomicsstatisticstoolvirtual
中文摘要
抽象-MIDUS总体规划
美国中年(MIDUS)国家纵向研究自1995年以来一直在进行。MIDUS是唯一
全国性的研究集中在基线年龄范围较大的中年人群。MIDUS还拥有不同寻常的深度
心理社会、生物标记物、基因组和神经科学评估,从而允许重点关注神经生物学
社会人口学和心理社会因素影响发病率和死亡率的机制和途径
死亡率。此应用程序旨在对MIDUS刷新样本进行第二波数据收集
(MR2)以及关于核心样本的第四波数据收集(M4),包括这两个项目的所有项目。四
项目(调查、每日日记、生物标记、基因组学)是U19竞争延续应用程序的一部分,
这与治疗阿尔茨海默病(AD)和相关痴呆(ADRD)的辅助U01应用程序有关
这将研究认知衰退、情绪调节、大脑老化及其相互作用的中年前驱症状。
以前的大部分工作也是纵向的,尽管现在包括了新的ADRD神经科学和生物标记物。
总体而言,拟议的活动涉及5200多名美国成年人,将得到行政核心的支持
负责协调跨项目的数据收集,并提供高质量、有良好记录的数据;a
BioCore,确保生物标志物数据收集的质量控制,并就生物标志物的使用提供指导;
以及提供多个主题研讨会的统计核心(使用基因组对纵向变化进行建模
数据,将MIDUS链接到其他数据集)。在拟议的科学中反复出现的科学主题是健康
利用MIDUS提供的丰富的生物、心理和社会数据审查了不平等和种族差异,包括
对多波压力暴露的广泛评估,从而提供了
累积的逆境。MIDUS还以其对心理和社会问题的全面评估而闻名
行为保护性因素,从而推进了对面对挑战的韧性的研究。随着年龄的增长而老化
不断变化的历史阶段是MIDUS的另一个关键主题,过去对
大衰退,以及未来,新的平行关注新冠肺炎大流行的困难。在以下方面
在科学参与方面,MIDUS是美国国家档案馆下载次数最多的研究
计算机化的老龄化数据(NACDA)。科学界的广泛使用(26,000+公众
已经出版了1,617份出版物,涉及38个实质性领域。强调这一势头
在MIDUS背后,这些产品中有一半以上是在当前资金周期内发表的期刊论文
(2016-至今)。
英文摘要
ABSTRACT – MIDUS OVERALL PLAN
The Midlife in the U.S. (MIDUS) national longitudinal study has been ongoing since 1995. MIDUS is the only
national study focused on midlife with a wide age expanse at baseline. MIDUS also has unusual depth in its
psychosocial, biomarker, genomic, and neuroscience assessments, thus permitting a focus on neurobiological
mechanisms and pathways through which sociodemographic and psychosocial factors influence morbidity and
mortality. This application aims to conduct a 2nd wave of data collection on the MIDUS Refresher sample
(MR2) as well as a 4th wave of data collection on the Core sample (M4), including all projects in both. Four
projects (Survey, Daily Diary, Biomarkers, Genomics) are part of this U19 competing continuation application,
which is linked with an Ancillary U01 application on Alzheimer’s Disease (AD) and Related Dementias (ADRD)
that will examine midlife precursurs to cognitive decline, emotion regulation, brain aging, and their interplay.
Much of that prior work is also longitudinal, although it now includes new ADRD neuroscience and biomarkers.
Overall, the proposed activities involve over 5,200 U.S. adults that will be supported by an Administrative Core
responsible for orchestrating cross-project data collection and delivering high-quality, well-documented data; a
BioCore that ensures quality control in biomarker data collection and offers guidance on use of biomarkers;
and a Statistics Core that provides workshops on multiple topics (modeling longitudinal change, using genomic
data, linking MIDUS to other datasets). Recurring scientific themes in the proposed science are health
inequalities and racial disparities examined with the rich biopsychosocial data available in MIDUS, including
wide-ranging assessments of stress exposures across multiple waves, thereby providing indicators of
cumulative adversity. MIDUS is also known for its comprehensive assessments of psychosocial and
behavioral protective factors, thereby advancing research on resilience in the face of challenge. Aging on a
changing historical stage is another key theme in MIDUS exemplified by a past focus on hardships of the
Great Recession, and going forward, a new parallel focus on hardships of the COVID-19 pandemic. In terms
of scientific engagement, MIDUS is the most frequently downloaded study at the National Archive of
Computerized Data on Aging (NACDA). Widespread usage from the scientific community (26,000+ public
users) has culminated in 1,617 publications covering 38 substantive domains. Underscoring the momentum
behind MIDUS, more than half of these products are journal articles published during the current funding cycle
(2016-present).
期刊论文(547)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/pere.12329
发表时间:
2020-09
期刊:
Personal Relationships
影响因子:
1.6
作者:
[Alen NV, Sloan RP, Seeman TE, Hostinar CE]
通讯作者:
Hostinar CE
DOI:
10.1037/per0000409
发表时间:
2021-01
期刊:
Personality disorders
影响因子:
--
作者:
[van Dijk I, Krueger RF, Laceulle OM]
通讯作者:
Laceulle OM
DOI:
10.1016/j.joep.2018.03.005
发表时间:
2018-06
期刊:
Journal Of Economic Psychology
影响因子:
3.5
作者:
[Ferrer R, Orehek E, Scheier MF, O'Connell ME]
通讯作者:
O'Connell ME
DOI:
10.1111/psyp.13622
发表时间:
2020-10
期刊:
Psychophysiology
影响因子:
3.7
作者:
[Knight EL, Giuliano RJ, Shank SW, Clarke MM, Almeida DM]
通讯作者:
Almeida DM
DOI:
10.1016/j.bpsc.2020.09.007
发表时间:
2021-04
期刊:
Biological psychiatry. Cognitive neuroscience and neuroimaging
影响因子:
--
作者:
[Lees B, Squeglia LM, McTeague LM, Forbes MK, Krueger RF, Sunderland M, Baillie AJ, Koch F, Teesson M, Mewton L]
通讯作者:
Mewton L
共 344 条
Project 2 -- MIDUS Daily Diary Project
-
批准号:10707327
-
项目类别:
-
资助金额:$75.1万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 3 -- MIDUS Biomarker Project
-
批准号:10559178
-
项目类别:
-
资助金额:$260.65万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:9321972
-
项目类别:
-
资助金额:$650.56万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core C -- Statistics Core
-
批准号:10707320
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 1 -- MIDUS Survey Project
-
批准号:10707322
-
项目类别:
-
资助金额:$120.37万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:9188963
-
项目类别:
-
资助金额:$647.79万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core A -- Administrative Core
-
批准号:10707315
-
项目类别:
-
资助金额:$74.85万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 4 -- MIDUS Genomics Project
-
批准号:10707335
-
项目类别:
-
资助金额:$56.91万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 4 -- MIDUS Genomics Project
-
批准号:10559179
-
项目类别:
-
资助金额:$59.68万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core A -- Administrative Core
-
批准号:10559173
-
项目类别:
-
资助金额:$75.52万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:10004314
-
项目类别:
-
资助金额:$11.92万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Core C -- Statistics Core
-
批准号:10559175
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:10621477
-
项目类别:
-
资助金额:$110.25万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 1 -- MIDUS Survey Project
-
批准号:10559176
-
项目类别:
-
资助金额:$163.05万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Integrative Pathways to Health and Illness
-
批准号:10559172
-
项目类别:
-
资助金额:$718.46万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 3 -- MIDUS Biomarker Project
-
批准号:10707331
-
项目类别:
-
资助金额:$263.48万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 2 -- MIDUS Daily Diary Project
-
批准号:10559177
-
项目类别:
-
资助金额:$66.55万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Project 1 - Changes in Daily Stress and Well-Being
-
批准号:10621481
-
项目类别:
-
资助金额:$110.25万
-
财政年份:2016
-
负责人:CAROL D. RYFF
-
依托单位:
Longitudinal Perspectives on Race and Health in MIDUS: Insights from Milwaukee
-
批准号:8814956
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2015
-
负责人:CAROL D. RYFF
-
依托单位:
Longitudinal Perspectives on Race and Health in MIDUS: Insights from Milwaukee
-
批准号:9134590
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:CAROL D. RYFF
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: